Saturday, July 11, 2026

pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON

Disc Medicine

Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip

321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
443
Patents
706
Clinical program

Mineral-enriched powder

Phase 2 · other · Iron Deficiency

Mineral-enriched powder for Iron Deficiency is a Phase 2 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).

← All Disc Medicine projects Phase 2 other completed

Internal code LIFE2022RCT2

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Disc Medicine
Phase
Phase 2
Modality
other
Indication
Iron Deficiency
Status
completed
Trials
1

Clinical trials